AMN Healthcare's Profit Nearly Tripled — But Two of Its Three Divisions Are Still Shrinking
AMN Healthcare reported Q2 2026 revenue of $673.2 million, up 2% year over year, and adjusted EPS of $0.77 — more than double the $0.19 analysts expected. The beat was driven almost entirely by Nurse and Allied Solutions, which grew 11% and included $25 million from a labor disruption, while Physician and Leadership Solutions and Technology and Workforce Solutions both kept shrinking. AMN shares jumped as much as 12.8%.
- AMN Healthcare reported Q2 2026 revenue of $673.2 million, up 2% year over year and above the $628.35 million analyst estimate.
- Adjusted diluted EPS was $0.77, more than quadruple the $0.19 analysts expected and up from $0.30 a year earlier; GAAP diluted EPS was $0.53 on net income of $21.2 million, reversing a $116 million net loss in the year-ago quarter. Adjusted EBITDA rose 26% year over year to $73.4 million.
- Nurse and Allied Solutions, the company's largest segment, drove the beat: revenue rose 11% to $422 million, with travel nurse staffing up 10% and allied staffing up 8% — a labor disruption alone contributed $25 million of that revenue.
Reaction by asset (real prices)
| Asset | 2m before | At release | +1m | +15m | +1m % | +15m % |
|---|---|---|---|---|---|---|
| AMN | 31.05 | 31.05 | 31.05 | 35.03 | 0.00% | +12.82% |
AMN Healthcare reported second-quarter 2026 revenue of $673.2 million, up 2% year over year and above the $628.35 million analysts expected. The headline number was adjusted diluted EPS of $0.77 — more than quadruple the $0.19 analysts had modeled, and up from $0.30 in the same quarter last year. GAAP diluted EPS was $0.53 on net income of $21.2 million, a sharp reversal from a $116 million net loss a year earlier. Adjusted EBITDA rose 26% year over year to $73.4 million.
The beat was not broad-based. AMN Healthcare operates through three segments, and only one of them grew: Nurse and Allied Solutions, the largest, rose 11% to $422 million, with travel nurse staffing up 10% and allied staffing up 8%. Notably, a labor disruption alone contributed $25 million of that segment's revenue — a one-time tailwind rather than pure organic demand recovery, meaning the underlying growth rate in the core nursing business is likely softer than the headline 11% suggests.
The other two segments kept shrinking. Physician and Leadership Solutions revenue fell 6% to $165 million as locum tenens staffing — temporary physician placements — dropped 8%, partly offset by a 27% surge in executive search. Technology and Workforce Solutions fell 15% to $87 million as language services declined 8%. Both trends continued from prior quarters rather than reversing.
AMN guided third-quarter 2026 consolidated revenue to $640 million to $655 million, 1% to 3% growth, with Nurse and Allied still expected up 9% to 11% while Physician and Leadership is guided down 5% to 7% — the same divergent pattern as the quarter just reported. AMN shares jumped as much as 12.8% on the report. A beat this large against a segment mix this mixed — one large division recovering, including a one-time boost, against two smaller ones still declining — signals the market is pricing in relief that the company's biggest, most cyclical business has turned a corner, more than it is pricing in a broad recovery across all of healthcare staffing.
Sources
-
AMN Healthcare Announces Second Quarter 2026 Results
— PR Newswire (official company release)
Official Q2 2026 financial results, segment detail, and Q3 guidance
-
AMN Healthcare Services (NYSE:AMN) Delivers Strong Q2 CY2026 Numbers, Stock Jumps 11.5%
— StockStory / FinancialContent
Independent confirmation of results and market reaction
Never miss the next market-moving story
Follow the core market-moving feed across equities, macro, currencies and commodities. Your subscription includes price moves after the news, search, watchlists, alerts and research tools.
Create free accountGo real time Watch live headlines -- free